This is delivery-system IP strategy working exactly as intended: the innovator uses the primary patent exclusivity window to develop and patent a better delivery system, so when generics enter the base product, the market has migrated to the next platform
Its safety, efficacy, appropriate dosing, and long-term effects in humans have not been established
622-6, DOI:10.1055/s-2007-1004988, PMID 1981766
31 Elevated levels of 3-NT have been described in a number of diseases with an oxidative stress pathology, including alcoholism, smoking, diabetes, atherosclerosis and cystic fibrosis
The weight-loss medications semaglutide (Wegovy) and tirzepatide (Zepbound) have been game changers for millions of Americans who want to shed extra pounds